131 related articles for article (PubMed ID: 31323279)
1. Impaired hippocampal and thalamic acetylcholine release in P301L tau-transgenic mice.
Stein C; Koch K; Hopfeld J; Lobentanzer S; Lau H; Klein J
Brain Res Bull; 2019 Oct; 152():134-142. PubMed ID: 31323279
[TBL] [Abstract][Full Text] [Related]
2. MRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance.
García-Gómez BE; Fernández-Gómez FJ; Muñoz-Delgado E; Buée L; Blum D; Vidal CJ
J Mol Neurosci; 2016 Apr; 58(4):411-5. PubMed ID: 26697857
[TBL] [Abstract][Full Text] [Related]
3. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy.
Köhler C; Bista P; Götz J; Schröder H
Brain Res; 2010 Aug; 1347():111-24. PubMed ID: 20513372
[TBL] [Abstract][Full Text] [Related]
5. Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices.
Kar S; Issa AM; Seto D; Auld DS; Collier B; Quirion R
J Neurochem; 1998 May; 70(5):2179-87. PubMed ID: 9572306
[TBL] [Abstract][Full Text] [Related]
6. Neurotransmitters and energy metabolites in amyloid-bearing APP(SWE)xPSEN1dE9 Mouse Brain.
Hartmann J; Kiewert C; Klein J
J Pharmacol Exp Ther; 2010 Feb; 332(2):364-70. PubMed ID: 19846589
[TBL] [Abstract][Full Text] [Related]
7. Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase.
Erb C; Troost J; Kopf S; Schmitt U; Löffelholz K; Soreq H; Klein J
J Neurochem; 2001 Apr; 77(2):638-46. PubMed ID: 11299326
[TBL] [Abstract][Full Text] [Related]
8. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice.
Hartmann J; Erb C; Ebert U; Baumann KH; Popp A; König G; Klein J
Neuroscience; 2004; 125(4):1009-17. PubMed ID: 15120860
[TBL] [Abstract][Full Text] [Related]
9. Choline availability and acetylcholine synthesis in the hippocampus of acetylcholinesterase-deficient mice.
Hartmann J; Kiewert C; Duysen EG; Lockridge O; Klein J
Neurochem Int; 2008 May; 52(6):972-8. PubMed ID: 18023504
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the Septo-Hippocampal Cholinergic Pathway in Association with Septal Acetylcholinesterase Upregulation in a Mouse Model of Tauopathy.
Hara Y; Motoi Y; Hikishima K; Mizuma H; Onoe H; Matsumoto SE; Elahi M; Okano H; Aoki S; Hattori N
Curr Alzheimer Res; 2017; 14(1):94-103. PubMed ID: 27335039
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer's-like Tauopathy Mouse Model.
Zadrozny M; Drapich P; Gasiorowska-Bien A; Niewiadomski W; Harrington CR; Wischik CM; Riedel G; Niewiadomska G
Cells; 2024 Apr; 13(7):. PubMed ID: 38607082
[TBL] [Abstract][Full Text] [Related]
12. Increased Cholinergic Response in α-Synuclein Transgenic Mice (h-α-synL62).
König M; Berlin B; Schwab K; Frahm S; Theuring F; Wischik CM; Harrington CR; Riedel G; Klein J
ACS Chem Neurosci; 2019 Apr; 10(4):1915-1922. PubMed ID: 30253092
[TBL] [Abstract][Full Text] [Related]
13. Administration of amyloid beta-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo.
Abe E; Casamenti F; Giovannelli L; Scali C; Pepeu G
Brain Res; 1994 Feb; 636(1):162-4. PubMed ID: 8156403
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholine synthesis and release following continuous intracerebral administration of NGF in adult and aged Fischer-344 rats.
Rylett RJ; Goddard S; Schmidt BM; Williams LR
J Neurosci; 1993 Sep; 13(9):3956-63. PubMed ID: 8366354
[TBL] [Abstract][Full Text] [Related]
15. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
[TBL] [Abstract][Full Text] [Related]
16. Hydromethylthionine enhancement of central cholinergic signalling is blocked by rivastigmine and memantine.
Kondak C; Riedel G; Harrington CR; Wischik CM; Klein J
J Neurochem; 2022 Jan; 160(2):172-184. PubMed ID: 34855998
[TBL] [Abstract][Full Text] [Related]
17. Effect of tianeptine on the central cholinergic system: involvement of serotonin.
Bertorelli R; Amoroso D; Girotti P; Consolo S
Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):276-81. PubMed ID: 1620232
[TBL] [Abstract][Full Text] [Related]
18. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
Härtig W; Saul A; Kacza J; Grosche J; Goldhammer S; Michalski D; Wirths O
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):106-20. PubMed ID: 23566195
[TBL] [Abstract][Full Text] [Related]
19. Veratridine-induced breakdown of cytosolic acetylcholine in rat hippocampal minces: an intraterminal form of acetylcholinesterase or choline O-acetyltransferase?
Carroll PT; Badamchian M; Craig P; Lyness WH
Brain Res; 1986 Sep; 383(1-2):83-99. PubMed ID: 3768708
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane alleviates scopolamine-induced memory impairment in mice.
Lee S; Kim J; Seo SG; Choi BR; Han JS; Lee KW; Kim J
Pharmacol Res; 2014 Jul; 85():23-32. PubMed ID: 24836869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
